Pharmaceuticals

The libido-enhancing drug approved by an FDA advisory panel acts slowly on the brain to increase desire—not quickly on the mechanics of the sexual act

A drug to treat low female sexual desire should be approved with strict measures in place to ensure patients are fully aware of its risks, the advisory panel said

Even if the U.S. Food and Drug Administration approves a new drug for boosting women's sexual desire, it is unlikely to work the same magic on a couple's sex life as "the little blue pill"

At least 70 percent of mice treated with one of these common drugs survived Ebola infection

An experimental leishmaniasis vaccine relies on eliciting an immune response to a protein from the saliva of the sand fly that carries the leishmania parasite, rather than on anything from the parasite itself. Cynthia Graber reports

A newly discovered structure in cells underlies inflammation wherever it occurs—an insight that may lead to new treatments for ailments as diverse as atherosclerosis, Alzheimer's and fatty liver disease

A DNA-based vaccine gave rats six months of protection against high blood pressure as well as healthier hearts. Christopher Intagliata reports

The proposed deals have the potential to boost research but could also weaken health and environmental protections

From predatory microbes to toxic metals, nature is inspiring new ways to treat infections

Accelerated testing of compounds that have shown efficacy against the virus may lead to new drugs and vaccines

Three strains of the virus are decimating poultry farms across the country, but how they’re being transmitted remains unclear

Microbes that clean water may also be piecing some pharmaceuticals back together